BPC-157 / TB-500

The BPC-157 / TB-500 blend combines two distinct research materials in one presentation. BPC-157 is a synthetic 15-amino-acid peptide investigated primarily in gastrointestinal, vascular, and connective-tissue models. TB-500 is a commercial research name commonly associated with a synthetic fragment related to thymosin beta-4; the exact sequence supplied must be verified because TB-500 should not automatically be described as full-length thymosin beta-4.

The scientific rationale for studying the components together is based on potentially complementary preclinical pathways. BPC-157 research has examined nitric-oxide and angiogenic signaling, inflammatory mediators, cytoprotection, and extracellular-matrix organization. Thymosin-beta-4-related research has examined actin binding, cell migration, endothelial responses, angiogenesis, and wound-repair biology. A blend does not establish synergy, superiority, safety, or efficacy, and combination-specific evidence is substantially more limited than the evidence for either component studied separately.